A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

Clinical trial NCT05813925 · COMPLETED

Trial details

NCT number: NCT05813925
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity or Overweight

Start date: 2023-04-03
Primary completion: 2025-01-17
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.